A stepwise implementation of the Slovenian National Diabetic Retinopathy Screening Program - evaluation of the first 4.5 years.

IF 1.4 4区医学 Q3 OPHTHALMOLOGY

European Journal of Ophthalmology Pub Date : 2025-03-01 Epub Date: 2024-08-02 DOI:10.1177/11206721241267029

Marko Šulak, Kristina Jevnikar, Fran Drnovšek, Levin Vrhovec, Mojca Urbančič, Maja Potrč, Angela Thaler, Neža Čokl, Jelka Zaletel, Mojca Globočnik Petrovič

{"title":"A stepwise implementation of the Slovenian National Diabetic Retinopathy Screening Program - evaluation of the first 4.5 years.","authors":"Marko Šulak, Kristina Jevnikar, Fran Drnovšek, Levin Vrhovec, Mojca Urbančič, Maja Potrč, Angela Thaler, Neža Čokl, Jelka Zaletel, Mojca Globočnik Petrovič","doi":"10.1177/11206721241267029","DOIUrl":null,"url":null,"abstract":"Background: This retrospective cohort study aimed to assess the characteristics of patients enrolled in the national diabetic retinopathy (DR) screening program and evaluate the selected program's quality elements in the first five years after implementation.Methods: Patients who underwent DR screening between February 2018 and June 2022 at the University Medical Centre Ljubljana were included. General patient characteristics (age, sex, type and therapy of diabetes mellitus (DM), duration of DM, blood HbA1c levels), best corrected visual acuity, stage of DR, presence of sight-threatening diabetic retinopathy (STDR), and selected quality indicators (quality of photographs, re-screening interval, time to treatment) were recorded and evaluated.Results: A total of 34 654 screening examinations were performed on 13 513 patients with diabetes. The majority (77.3%) had Type 2 diabetes, with a mean DM duration of 9.74 ± 9.87 years. In 55.9% of patients, DM duration was less than ten years, and the mean HbA1c was 7.33% ± 1.49. DR signs were noted in 29.1% of patients and 0.89% of patients exhibited STDR. After establishing the diagnosis of STDR, treatment was initiated in 3.43 ± 1.98 months.Conclusion: Implementing the DR screening program provides valuable insights into managing diabetic retinopathy nationwide. It allows for the early detection of sight-threatening DR and facilitates timely and effective treatment, which could help prevent severe visual impairment.","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"660-668"},"PeriodicalIF":1.4000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/11206721241267029","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: This retrospective cohort study aimed to assess the characteristics of patients enrolled in the national diabetic retinopathy (DR) screening program and evaluate the selected program's quality elements in the first five years after implementation.

Methods: Patients who underwent DR screening between February 2018 and June 2022 at the University Medical Centre Ljubljana were included. General patient characteristics (age, sex, type and therapy of diabetes mellitus (DM), duration of DM, blood HbA1c levels), best corrected visual acuity, stage of DR, presence of sight-threatening diabetic retinopathy (STDR), and selected quality indicators (quality of photographs, re-screening interval, time to treatment) were recorded and evaluated.

Results: A total of 34 654 screening examinations were performed on 13 513 patients with diabetes. The majority (77.3%) had Type 2 diabetes, with a mean DM duration of 9.74 ± 9.87 years. In 55.9% of patients, DM duration was less than ten years, and the mean HbA1c was 7.33% ± 1.49. DR signs were noted in 29.1% of patients and 0.89% of patients exhibited STDR. After establishing the diagnosis of STDR, treatment was initiated in 3.43 ± 1.98 months.

Conclusion: Implementing the DR screening program provides valuable insights into managing diabetic retinopathy nationwide. It allows for the early detection of sight-threatening DR and facilitates timely and effective treatment, which could help prevent severe visual impairment.

查看原文本刊更多论文

逐步实施斯洛文尼亚国家糖尿病视网膜病变筛查计划--对前 4.5 年的评估。

背景：这项回顾性队列研究旨在评估加入国家糖尿病视网膜病变（DR）筛查计划的患者特征，并评估选定计划实施后前五年的质量要素：方法：纳入2018年2月至2022年6月期间在卢布尔雅那大学医疗中心接受DR筛查的患者。记录并评估了患者的一般特征（年龄、性别、糖尿病（DM）类型和治疗方法、DM持续时间、血HbA1c水平）、最佳矫正视力、DR分期、是否存在危及视力的糖尿病视网膜病变（STDR）以及选定的质量指标（照片质量、复查间隔时间、治疗时间）：共为 13 513 名糖尿病患者进行了 34 654 次筛查。大多数（77.3%）患者为 2 型糖尿病，平均糖尿病病程为 9.74 ± 9.87 年。55.9%的患者糖尿病病程不到十年，平均 HbA1c 为 7.33% ± 1.49。29.1%的患者出现 DR 征兆，0.89% 的患者表现为 STDR。在确诊 STDR 后，开始治疗的时间为 3.43 ± 1.98 个月：糖尿病视网膜病变筛查项目的实施为全国糖尿病视网膜病变的管理提供了宝贵的意见。它可以及早发现危及视力的 DR，并促进及时有效的治疗，从而有助于防止严重视力损害的发生。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Ophthalmology 医学-眼科学

CiteScore

3.60

自引率

0.00%

发文量

372

审稿时长

3-8 weeks

期刊介绍： The European Journal of Ophthalmology was founded in 1991 and is issued in print bi-monthly. It publishes only peer-reviewed original research reporting clinical observations and laboratory investigations with clinical relevance focusing on new diagnostic and surgical techniques, instrument and therapy updates, results of clinical trials and research findings.